Author:
Serody Jonathan S.,Moran Timothy P.,Blazar Bruce R.
Reference117 articles.
1. Afessa, B., and Peters, S.G. (2008). Non-infectious pneumonitis after blood and marrow transplant. Curr Opin Oncol 20, 227–233.
2. Anagnastopoulos, A., Aleman, A., and Giralt, S. (2004). Non-myeloablative reduced-intensity transplantation in multiple myeloma. Semin Oncol 31, 33–36.
3. AS, O.M., and Cowan, M.J. (1997). Bone marrow transplantation for inherited diseases [see comments]. Current Opinion in Oncology 9, 126–130.
4. Asai, O., Longo, D.L., Tian, Z.G., Hornung, R.L., Taub, D.D., Ruscetti, F.W., and Murphy, W.J. (1998). Suppression of graft versus host disease and amplification of graft versus tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 101, 1835–1842.
5. Atreya, R., Mudter, J., Finotto, S., Mullberg, J., Jostock, T., Wirtz, S., Schutz, M., Bartsch, B., Holtmann, M., Becker, C. et al. (2000). Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn’s disease and experimental colitis in vivo. Nat Med 6, 583–588.